Episode 1 – Myasthenia gravis 101: Disease burden, diagnosis, treatment landscape, and outcomes

Update: 2023-07-27

Description

Professor Nils Erik Gilhus and Professor Jan De Bleecker discuss the impact of early diagnosis on patient outcomes and provide expert-led insight into the treatment options available to patients with MG based on the latest research.

Comments

In Channel

Episode 17 – The urgency of myasthenic crisis

2025-10-0822:04

Episode 16 - Life beyond MG

2025-03-2016:27

Episode 15 - The nature of myasthenia gravis

2025-03-2015:49

Episode 14 - New and improved assays for detecting antibodies

2024-09-2316:21

Episode 13 – EAN 2024 special

2024-07-2917:36

Episode 12 – Late-onset myasthenia gravis

2024-06-2818:01

Episode 11 – Steroids in myasthenia gravis

2024-05-1716:07

Episode 10 – Unmet needs in myasthenia gravis

2024-04-1915:43

Episode 9 – Pregnancy and myasthenia gravis

2024-03-2716:16

Episode 8 – Diagnostic delay in myasthenia gravis

2024-03-0718:10

Episode 7 – Physical exercise in myasthenia gravis

2024-01-2418:01

Episode 6 – Autoantibodies as biomarkers

2024-01-0514:56

Episode 5 – Myasthenia gravis: A global perspective

2023-11-1719:12

Episode 4 – Targeted therapies in myasthenia gravis

2023-10-2018:25

Episode 3 – Myasthenia gravis: A patient perspective

2023-09-1514:40

Episode 2 – EAN 2023: Highlights and key takeaways

2023-07-2722:22

Episode 1 – Myasthenia gravis 101: Disease burden, diagnosis, treatment landscape, and outcomes

2023-07-2719:23

00:00

Episode 1 – Myasthenia gravis 101: Disease burden, diagnosis, treatment landscape, and outcomes

#box-pro-ellipsis-176421840351068{-webkit-line-clamp:2;}Episode 1 – Myasthenia gravis 101: Disease burden, diagnosis, treatment landscape, and outcomes

Episode 1 – Myasthenia gravis 101: Disease burden, diagnosis, treatment landscape, and outcomes

medthority

Episode 1 – Myasthenia gravis 101: Disease burden, diagnosis, treatment landscape, and outcomes